Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-10 4:19 pm Purchase |
2025-04-03 | 13G | Merus N.V. MRUS |
Paradigm BioCapital Advisors LP | 3,554,059 5.100% |
3,554,059 (New Position) |
Filing History |
| 2025-03-27 4:21 pm Purchase |
2025-03-20 | 13G | LENZ Therapeutics, Inc. LENZ |
Paradigm BioCapital Advisors LP | 1,419,832 5.200% |
1,419,832 (New Position) |
Filing History |
| 2025-02-14 4:45 pm Purchase |
2024-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Paradigm BioCapital Advisors LP | 7,429,355 9.990% |
1,925,755 (+34.99%) |
Filing History |
| 2025-02-14 4:42 pm Sale |
2024-12-31 | 13G | Kura Oncology, Inc. KURA |
Paradigm BioCapital Advisors LP | 0 0.000% |
-4,331,321 (Position Closed) |
Filing History |
| 2025-02-14 4:41 pm Purchase |
2024-12-31 | 13G | Janux Therapeutics, Inc. JANX |
Paradigm BioCapital Advisors LP | 3,515,986 6.000% |
907,412 (+34.79%) |
Filing History |
| 2025-02-12 4:35 pm Purchase |
2025-02-05 | 13G | Cogent Biosciences, Inc. COGT |
Paradigm BioCapital Advisors LP | 5,559,924 5.000% |
5,559,924 (New Position) |
Filing History |
| 2025-02-03 4:36 pm Purchase |
2025-01-27 | 13G | Edgewise Therapeutics, Inc. EWTX |
Paradigm BioCapital Advisors LP | 4,738,929 5.000% |
4,738,929 (New Position) |
Filing History |
| 2024-11-14 4:35 pm Purchase |
2024-09-30 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Paradigm BioCapital Advisors LP | 2,440,445 6.400% |
512,939 (+26.61%) |
Filing History |
| 2024-11-14 4:35 pm Purchase |
2024-09-30 | 13G | Arcellx, Inc. ACLX |
Paradigm BioCapital Advisors LP | 4,800,000 8.900% |
1,141,376 (+31.20%) |
Filing History |
| 2024-11-14 4:35 pm Sale |
2024-09-30 | 13G | COMPASS Pathways plc CMPS |
Paradigm BioCapital Advisors LP | 2,320,000 3.300% |
-1,105,988 (-32.28%) |
Filing History |
| 2024-11-14 4:34 pm Sale |
2024-09-30 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Paradigm BioCapital Advisors LP | 5,503,600 9.600% |
-2,400,000 (-30.37%) |
Filing History |
| 2024-11-14 4:34 pm Purchase |
2024-09-30 | 13G | Nuvalent, Inc. NUVL |
Paradigm BioCapital Advisors LP | 5,000,000 7.800% |
1,141,992 (+29.60%) |
Filing History |
| 2024-11-14 4:33 pm Sale |
2024-09-30 | 13G | Vor Biopharma Inc. VOR |
Paradigm BioCapital Advisors LP | 0 0.000% |
-6,457,293 (Position Closed) |
Filing History |
| 2024-11-14 4:33 pm Sale |
2024-09-30 | 13G | Viridian Therapeutics, Inc. VRDN |
Paradigm BioCapital Advisors LP | 3,509,253 4.600% |
-1,795,060 (-33.84%) |
Filing History |
| 2024-11-14 4:33 pm Sale |
2024-09-30 | 13G | Disc Medicine, Inc. IRON |
Paradigm BioCapital Advisors LP | 1,497,720 5.040% |
-888,137 (-37.23%) |
Filing History |
| 2024-11-14 4:32 pm Sale |
2024-09-30 | 13G | Bicycle Therapeutics plc BCYC |
Paradigm BioCapital Advisors LP | 0 0.000% |
-3,707,001 (Position Closed) |
Filing History |
| 2024-11-14 4:32 pm Sale |
2024-09-30 | 13G | Autolus Therapeutics plc AUTL |
Paradigm BioCapital Advisors LP | 0 0.000% |
-12,611,335 (Position Closed) |
Filing History |
| 2024-11-14 4:32 pm Purchase |
2024-09-30 | 13G | Y-mAbs Therapeutics, Inc. YMAB |
Paradigm BioCapital Advisors LP | 4,086,346 9.200% |
1,888,034 (+85.89%) |
Filing History |
| 2024-11-14 4:31 pm Purchase |
2024-09-30 | 13G | Kura Oncology, Inc. KURA |
Paradigm BioCapital Advisors LP | 4,331,321 5.700% |
470,003 (+12.17%) |
Filing History |
| 2024-10-23 5:39 pm Purchase |
2024-10-16 | 13G | Janux Therapeutics, Inc. JANX |
Paradigm BioCapital Advisors LP | 2,608,574 5.000% |
2,608,574 (New Position) |
Filing History |